Item request has been placed!
×
Item request cannot be made.
×
Processing Request
TonEBP is inhibited by RNA helicase A via interaction involving the E'F loop.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Colla E;Colla E; Lee SD; Sheen MR; Woo SK; Kwon HM
- Source:
The Biochemical journal [Biochem J] 2006 Jan 01; Vol. 393 (Pt 1), pp. 411-9.
- Publication Type:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
- Language:
English
- Additional Information
- Source:
Publisher: Published by Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 2984726R Publication Model: Print Cited Medium: Internet ISSN: 1470-8728 (Electronic) Linking ISSN: 02646021 NLM ISO Abbreviation: Biochem J Subsets: MEDLINE
- Publication Information:
Original Publication: London, UK : Published by Portland Press on behalf of the Biochemical Society
- Subject Terms:
- Abstract:
TonEBP [TonE (tonicity-responsive enhancer)-binding protein] is a transcriptional activator of the Rel family like NF-kappaB (nuclear factor kappaB) and NFAT (nuclear factor of activated T-cells). TonEBP plays a key role in the protection of cells in the kidney medulla from the deleterious effects of hyperosmolality. This is achieved by enhancing expression of HSP70 (heat-shock protein 70) and other genes whose products drive cellular accumulation of organic osmolytes. TonEBP is stimulated by ambient hypertonicity via multiple pathways that regulate nuclear translocation and transactivation. In the present paper, we report that TonEBP is associated in vivo with RHA (RNA helicase A). The N- and C-termini of RHA bound the E'F loop of the DNA-binding domain of TonEBP. The interaction was not affected by DNA binding or dimerization of TonEBP. Overexpression of RHA inhibited the activity of TonEBP; however, catalytic activity of RHA was dispensable for the inhibition. When the ambient tonicity was raised, the TonEBP-RHA interaction decreased, suggesting that dissociation of RHA is a pathway to stimulate TonEBP. We conclude that the E'F loop of TonEBP interacts with RHA like NFAT and NF-kappaB interact with AP1 (activator protein 1) and the high-mobility group protein HMG-I(Y) respectively. While RHA interacts with and stimulates other transcription factors such as CREB (cAMP-response-element-binding protein), NF-kappaB and mineralocorticoid receptor, it inhibits TonEBP.
- References:
J Biol Chem. 2004 Apr 23;279(17):17134-41. (PMID: 14769796)
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2392-7. (PMID: 14983020)
Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10673-8. (PMID: 15247420)
Eur J Biochem. 2004 Sep;271(18):3741-51. (PMID: 15355351)
Cell. 1990 Nov 2;63(3):631-42. (PMID: 2171779)
Cell. 1991 Sep 6;66(5):935-47. (PMID: 1653648)
Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6958-62. (PMID: 1495986)
Am J Physiol. 1993 Sep;265(3 Pt 2):F416-24. (PMID: 8214101)
Nucleic Acids Res. 1994 Jul 11;22(13):2552-6. (PMID: 8041617)
Science. 1997 May 30;276(5317):1412-5. (PMID: 9162007)
Cell. 1997 Sep 19;90(6):1107-12. (PMID: 9323138)
Nature. 1998 Mar 5;392(6671):42-8. (PMID: 9510247)
Am J Physiol. 1998 Apr;274(4 Pt 2):F753-61. (PMID: 9575900)
Nat Genet. 1998 Jul;19(3):254-6. (PMID: 9662397)
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2538-42. (PMID: 10051678)
Mol Cell Biol. 1999 May;19(5):3540-50. (PMID: 10207077)
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7214-9. (PMID: 10377394)
J Biol Chem. 1999 Jul 16;274(29):20235-43. (PMID: 10400641)
J Immunol. 1999 Dec 1;163(11):6269-74. (PMID: 10570320)
Am J Physiol Cell Physiol. 2000 Feb;278(2):C323-30. (PMID: 10666027)
Am J Physiol Renal Physiol. 2000 Jun;278(6):F1006-12. (PMID: 10836989)
Am J Physiol Cell Physiol. 2001 Feb;280(2):C248-53. (PMID: 11208518)
Mol Biol Evol. 2001 Mar;18(3):330-43. (PMID: 11230534)
Nat Struct Biol. 2002 Feb;9(2):90-4. (PMID: 11780147)
Am J Physiol Renal Physiol. 2002 May;282(5):F802-9. (PMID: 11934689)
Mol Cell Biol. 2002 Jun;22(11):3698-706. (PMID: 11997506)
Biochem Biophys Res Commun. 2002 Jun 28;294(5):968-75. (PMID: 12074571)
Mol Cell Biol. 2002 Aug;22(16):5753-60. (PMID: 12138186)
Pflugers Arch. 2002 Aug;444(5):579-85. (PMID: 12194010)
Nucleic Acids Res. 2001 May 1;29(9):1915-25. (PMID: 11328875)
J Immunol. 2002 Nov 15;169(10):5477-88. (PMID: 12421923)
J Am Soc Nephrol. 2003 Feb;14(2):283-8. (PMID: 12538727)
Nucleic Acids Res. 2003 May 1;31(9):2253-60. (PMID: 12711669)
J Biol Chem. 2003 Nov 28;278(48):47571-7. (PMID: 12970349)
Neuroscience. 2004;124(1):89-104. (PMID: 14960342)
Acta Biochim Biophys Sin (Shanghai). 2004 Mar;36(3):177-83. (PMID: 15202501)
- Grant Information:
R01 DK061677 United States DK NIDDK NIH HHS; R01-DK61677 United States DK NIDDK NIH HHS
- Accession Number:
0 (Autoantigens)
0 (NFATC Transcription Factors)
0 (Neoplasm Proteins)
EC 3.6.1.- (DHX9 protein, human)
EC 3.6.4.13 (DEAD-box RNA Helicases)
EC 3.6.4.13 (RNA Helicases)
- Publication Date:
Date Created: 20050922 Date Completed: 20060316 Latest Revision: 20181113
- Publication Date:
20231215
- Accession Number:
PMC1383700
- Accession Number:
10.1042/BJ20051082
- Accession Number:
16173919
No Comments.